Clinical manifestation of angioimmunoblastic T-cell lymphoma with exuberant plasmacytosis

International Journal of Hematology

Volumn 98, Issue 3, 2013, Pages 366-374

  Nagoshi, Hisao ^a   Kuroda, Junya ^a   Kobayashi, Tsutomu ^a   Maegawa, Saori ^a   Chinen, Yoshiaki ^a   Kiyota, Miki ^a   Nakayama, Ryuko ^a   Mizutani, Shinsuke ^a   Shimura, Yuji ^a   Yamamoto Sugitani, Mio ^a   Matsumoto, Yosuke ^a   Horiike, Shigeo ^a   Taniwaki, Masafumi ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Angioimmunoblastic T cell lymphoma; Plasmacytosis; Polyclonal hyperglobulinemia; Prognosis

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN; INTERLEUKIN 2 RECEPTOR; LACTATE DEHYDROGENASE;

ADULT; AGED; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ARTICLE; BLOOD CELL COUNT; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; MALE; PLASMA CELL; PLASMACYTOSIS; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SYMPTOM;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOBLASTIC LYMPHADENOPATHY; IMMUNOGLOBULINS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; PLASMA CELLS; PROGNOSIS;

EID: 84884676198     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-013-1411-z     Document Type: Article

References (28)

1. Dogan A, Attygalle AD, Kyriakou C. Angioimmunoblastic T-cell lymphoma. Br J Haematol. 2003;121:681-91.
2. Iannitto E, Ferreri AJ, Minardi V, Tripodo C, Kreipe HH. Angioimmunoblastic T-cell lymphoma. Crit Rev Oncol Hematol. 2008;68:264-71.
3. Armitage JO. The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and management. Am J Hematol. 2012;87:511-9.
4. Ren YL, Nong L, Zhang S, Zhao J, Zhang XM, Li T. Analysis of 142 Northern Chinese patients with peripheral T/NK-Cell lymphomas: subtype distribution, clinicopathologic features, and prognosis. Am J Clin Pathol. 2012;138:435-47.
5. Kihara R, Watanabe T, Yano T, Uike N, Okamura S, Kawano F, et al. Prognosis of mature T cell lymphoma is poorer than that of diffuse large B cell lymphoma in IPI low-risk group, but not in intermediate- and high-risk groups. Int J Hematol. 2013;97:98-102.
6. Federico M, Rudiger T, Bellei M, Nathwani BN, Luminari S, Coiffier B, et al. Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J Clin Oncol. 2013;31:240-6.
7. Tokunaga T, Shimada K, Yamamoto K, Chihara D, Ichihashi T, Oshima R, et al. Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan. Blood. 2012;119:2837-43.
8. Mourad N, Mounier N, Brière J, Raffoux E, Delmer A, Feller A, et al. Groupe d'Etude des Lymphomes de l'Adulte. Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. Blood. 2008;111:4463-70.
9. Hsu SM, Waldron JA Jr, Fink L, King C, Xie SS, Mansouri A, et al. Pathogenic significance of interleukin-6 in angioimmunoblastic lymphadenopathy-type T-cell lymphoma. Hum Pathol. 1993;24:126-31.
10. Grogg KL, Morice WG, Macon WR. Spectrum of bone marrow findings in patients with angioimmunoblastic T-cell lymphoma. Br J Haematol. 2007;137:416-22.
11. Dupuis J, Boye K, Martin N, Copie-Bergman C, Plonquet A, Fabiani B, et al. Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am J Surg Pathol. 2006;30:490-4.
12. Iqbal J, Weisenburger DD, Greiner TC, Vose JM, McKeithan T, Kucuk C, International Peripheral T-Cell Lymphoma Project, et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood. 2010;115:1026-36.
13. Sekiguchi Y, Matsuzawa N, Shimada A, Imai H, Wakabayashi M, Sugimoto K, et al. Angioimmunoblastic T-cell lymphoma with intramedullary production of platelet-derived growth factor and possibly complicating myelofibrosis: report of a case with review of the literature. Int J Hematol. 2013 (in print).
14. Attygalle AD, Chuang SS, Diss TC, Du MQ, Isaacson PG, Dogan A. Distinguishing angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified, using morphology, immunophenotype and molecular genetics. Histopathology. 2007;50:498-508.
15. Papadi B, Polski JM, Clarkson DR, Liu-Dumlao TO. Atypical angioimmunoblastic T-cell lymphomas masquerading as systemic polyclonal B-immunoblastic proliferation. Virchows Arch. 2012;461:323-31.
16. Ahsanuddin AN, Brynes RK, Li S. Peripheral blood polyclonal plasmacytosis mimicking plasma cell leukemia in patients with angioimmunoblastic T-cell lymphoma: report of 3 cases and review of the literature. Int J Clin Exp Pathol. 2011;4:416-20.
17. Sakai H, Tanaka H, Katsurada T, Yoshida Y, Okamoto E, Ohno H. Angioimmunoblastic T-cell lymphoma initially presenting with replacement of bone marrow and peripheral plasmacytosis. Intern Med. 2007;46:419-24.
18. Yamane A, Awaya N, Shimizu T, Ikeda Y, Okamoto S. Angioimmunoblastic T-cell lymphoma with polyclonal proliferation of plasma cells in peripheral blood and marrow. Acta Haematol. 2007;117:74-7.
19. Kobayashi T, Kuroda J, Uchiyama H, Matsumoto Y, Horiike S, Taniwaki M. Successful treatment of chemotherapy-refractory angioimmunoblastic T cell lymphoma with cyclosporin A. Acta Haematol. 2012;127:10-5.
20. Matsumura Y, Kuroda J, Shimura Y, Kiyota M, Yamamoto-Sugitani M, Kobayashi T, et al. Cyclosporine A and reduced-intensity conditioning allogeneic stem cell transplantation for relapsed angioimmunoblastic T cell lymphoma with hemophagocytic syndrome. Intern Med. 2012;51:2785-7.
21. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993;329:987-94.
22. Gallamini A, Stelitano C, Calvi R, Bellei M, Mattei D, Vitolo U, Intergruppo Italiano Linfomi, et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood. 2004;103:2474-9.
23. Fernández de Larrea C, Kyle RA, Durie BG, Ludwig H, Usmani S, Vesole DH, et al. Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia. 2013;27:780-91.
24. Pellat-Deceunynck C, Bataille R. Normal and malignant human plasma cells: proliferation, differentiation, and expansions in relation to CD45 expression. Blood Cells Mol Dis. 2004;32:293-301.
25. Jego G, Robillard N, Puthier D, Amiot M, Accard F, Pineau D, et al. Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells. Blood. 1999;94:701-12.
26. Li L, Hsu P, Patel K, Saffari Y, Ashley I, Brody J. Polyclonal plasma cell proliferation with marked hypergammaglobulinemia and multiple autoantibodies. Ann Clin Lab Sci. 2006;36:479-84.
27. Ebara S, Song SN, Mizuta H, Ito Y, Hasegawa K, Kamata T, et al. Interleukin-6-producing dermoid cyst associated with multicentric Castleman's disease. Int J Hematol. 2012;95:198-203.
28. Advani R, Horwitz S, Zelenetz A, Horning SJ. Angioimmunoblastic T cell lymphoma: treatment experience with cyclosporine. Leuk Lymphoma. 2007;48:521-5.